REVB Revelation Biosciences Inc Net earnings per share growth forecast for next year
The stable R&D staff at Revelation Biosciences (REVB) creates a foundation for a technological breakthrough. The company's prospects rely on the efficacy of molecules against sepsis and the activation of innate immunity. This chart of the consensus EPS n+1 forecast visualizes these expectations, where 7.00 captures the current state of the parameter. The growth potential is confirmed by the integration of REVTx-99 into respiratory defense systems against viruses.
Metric breakdowns and analytics for Revelation Bio (REVB)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Revelation Biosciences|REVB - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Revelation Bio|REVB - Company Debts|Debts to Book Capitalization Revelation Biosciences|REVB - Long-Term Debt|Company Short-Term Debt Revelation Biosciences|Quick Ratio revbiosciences.com
- earnings and valuation multiples information:
REVB - Net Profit|Future Profit Revelation Biosciences|REVB - Market Price to Net Income Ratio|Forward P/E Multiple Revelation Biosciences Inc|REVB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences|REVB - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Revelation Biosciences|REVB - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months revbiosciences.com|REVB - Earnings per share increase in current year|Earnings growth forecast for next year Revelation Biosciences
- total revenue and sales volume data:
Summary company analysis:Revelation Biosciences Inc, REVB
Revelation Biosciences relies on the scientific potential of immunological platforms, yet its financial stability is critically dependent on external funding. The earnings per share growth model for next year digitizes analyst consensus forecasts for EPS dynamics, allowing investors to assess the business scaling speed and the risks of asset overvaluation should market conditions shift.
Competitors of Revelation Biosciences
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year biontech.de|Net earnings per share growth forecast for next year Abivax Corp (ABVX)|ADMA Biologics, Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (protagonist-inc.com)|Immunovant Corp (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year grifols.com (GRFS)|ADPT: Earnings growth forecast for next year|Expected net earnings per share growth next year Celldex Therapeutics Inc (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharma|Expected net earnings per share growth next year BioCryst Pharmaceuticals Inc BCRX|Earnings growth forecast for next year VERA|Dianthus Therapeutics, Inc. - Projected earnings per share growth rate for next year|Pharvaris - Expected earnings per share growth for next year|AbCellera Biologics Inc. - Net earnings per share growth forecast for next year|Tourmaline Bio Inc - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Intrexon (PGEN)|Pharming Group (PHAR) - Net earnings per share growth forecast for next year|Nektar Therapeutics Inc. - Expected earnings per share trend next year|Expected earnings per share growth for next year UPB|Zenas Bio (ZBIO) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNM (Immunome Corp)|GOSS (Gossamer Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|Consensus forecast of earnings per share growth for next year septerna.com (SEPN)|PVLA - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Savara Inc SVRA|RIGL: Earnings growth forecast for next year|ANAB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Astria Pharma|Projected earnings per share growth rate for next year ENGN (enGene Holdings Inc.)|Expected earnings per share growth for next year RAPT (RAPT Therapeutics, Inc.)|Earnings growth forecast for next year Aerovate Therapeutics, Inc. (JBIO)|Earnings growth forecast for next year ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Expected net earnings per share growth next year|tizianalifesciences.com - Earnings growth forecast for next year|CABA (Cabaletta Bio, Inc.) - Projected earnings per share growth rate for next year|VTYX: Earnings growth forecast for next year|THTX - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Avalo Therapeutics Inc|Eledon (ELDN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year ZURA (zurabio.com)|Expected earnings per share trend next year ATYR|ADAG - Net earnings per share growth forecast for next year|ikenaoncology.com (IMA) - Expected earnings per share growth for next year|Shattuck Labs (STTK) - Net earnings per share growth forecast for next year|EQ - Consensus forecast of earnings per share growth for next year|CNTB (connectbiopharm.com) - Earnings growth forecast for next year|IMUX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Atara Biotherapeutics, Inc. (ATRA)|Consensus forecast of earnings per share growth for next year InflaRx NV|Earnings growth forecast for next year XFOR (X4 Pharmaceuticals)|Earnings growth forecast for next year Adicet Bio ACET|CELU: Expected earnings per share growth for next year|Expected earnings per share trend next year INMB (INmune Bio)|Barinthus Bio (BRNS) - Net earnings per share growth forecast for next year|Kezar Life Sciences (KZR) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year sabbiotherapeutics.com|Earnings growth forecast for next year Akari Therapeutics Plc|Net earnings per share growth forecast for next year Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year GeoVax Corp GOVX|Consensus forecast of earnings per share growth for next year Edesa Biotech Corp (EDSA)|IBIO: Expected earnings per share growth for next year|Expected earnings per share trend next year CARM (carismatx.com)|XTLB: Earnings growth forecast for next year|BOLT - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year HCWB|Expected earnings per share growth for next year Aptevo Therapeutics Inc. (APVO)|Earnings growth forecast for next year AIM|ADTX: Net earnings per share change forecast for next year|GRI Bio - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year XORTX Therapeutics Inc (XRTX)|HIND: Expected earnings per share growth for next year|INDP - Earnings growth forecast for next year|SCNI: Earnings growth forecast for next year|Expected earnings per share growth for next year CalciMedica Inc|AFMD (Affimed Therapeutics) - Earnings growth forecast for next year|allakos.com (ALLK) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGM Biosciences Inc. (IGMS) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year iteostherapeutics.com ITOS|OCEA - Expected earnings per share growth for next year|TC BioPharm (Holdings) Plc - Earnings growth forecast for next year|Expected earnings per share trend next year THRD (Third Harmonic Bio, Inc.)
